Clarithromycin: Clinical Trials

68 trials of Clarithromycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

63 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 68 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 168Completed 63, Unknown 2, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 25Completed 4, Recruiting 1

Follow Clarithromycin: new trials by email Literature Review of Clarithromycin trials Research Report on Clarithromycin

Trials (filtered) newest first · largest first

All 68 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet
RSS0343 Tablet; Rifampicin Capsules, RSS0343 Tablet; Clarithromycin Tablets - Non-cystic Fibrosis Bronchiectasis、Chronic Sinusitis Without Nasal Polyps、Chronic Obstructive Pulmonary Disease
Phase 1Not yet recruitingReistone Biopharma Company Limited402026-07-012026-07-10
Drug Interaction Study on Linaprazan Glurate Capsules
Linaprazan Glurate Capsules, Bismuth Potassium Citrate Capsules, Amoxicillin Capsules - Healthy Volunteers, Patients
Phase 1CompletedJiangsu Sinorda Biomedicine Co., Ltd562025-09-082026-01-06
Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects
HRS-5965 Capsules, Clopidogrel, Clarithromycin - Complement Mediated Glomerular Diseases, Hemolytic Anemia
Phase 1CompletedChengdu Suncadia Medicine Co., Ltd.362025-07-082025-08-20
A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults
PF-07328948, cyclosporine, clarithromycin - Healthy Adults
Phase 1CompletedPfizer262025-03-192026-02-02
Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin
Midazolam, Clarithromycin, TNP-2198 - Helicobacter Pylori Infection
Phase 1CompletedTenNor Therapeutics Inc.322024-08-262024-10-24
A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants
KP-001, Metformin, Midazolam - Healthy Adults
Phase 1CompletedKaken Pharmaceutical382023-12-152025-03-07
Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults
DA-8010 5mg, Clarithromycin 500mg, Rifampicin 600mg - Healthy
Phase 1CompletedDong-A ST Co., Ltd.182023-08-182024-01-25
Effect of Pharmacokinetics in Healthy Chinese Subjects
Mindeudesivir hydrobromide tablets and Clarithromycin tablets, Mindeudesivir hydrobromide tablets and Cyclosporine softgels - The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects
Phase 1CompletedShanghai Vinnerna Biosciences Co., Ltd.362023-08-152025-06-29
A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants
Brensocatib, Clarithromycin - Healthy Volunteers
Phase 1CompletedInsmed Incorporated222023-07-282023-12-11
Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin
Tegoprazan, Bismuth, Amoxicilli - Healthy
Phase 1CompletedShandong Luoxin Pharmaceutical Group Stock Co., Ltd.222023-03-232023-06-23
Electrophysiological Effects of Potential QT Prolonging Drugs
Clarithromycin, Pimozide, Placebo (Part 1) - Drug-induced QT Prolongation, Pharmacokinetics
Phase 1CompletedFood and Drug Administration (FDA)442023-03-212023-06-22
Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam
Linaprazan glurate, Drug drug interaction (DDI) - Clarithromycin (Part I), Drug drug interaction (DDI) - Midazolam (Part 2) - Safety Issues, Pharmacokinetics
Phase 1CompletedCinclus Pharma Holding AB352022-11-272025-01-03
A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
LY3502970, Clarithromycin - Healthy
Phase 1CompletedEli Lilly and Company262022-08-012026-05-27
Furazolidone Quadruple Regimen Eradicate H. Pylori Infection
Furazolidone, Clarithromycin - Helicobacter Pylori Infection, Eradication
Phase 1 / Phase 2CompletedLiaocheng People's Hospital4932022-08-012025-02-12
The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)
Givinostat, Clarithromycin - Drug Drug Interaction
Phase 1CompletedItalfarmaco202022-03-212024-08-16
A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects
ATI-2173, Midazolam, Clarithromycin - Drug Drug Interaction
Phase 1CompletedAntios Therapeutics, Inc362021-10-282022-02-04
Effect of Clarithromycin and Rifampicin on the Pharmacokinetics of XZP-3287 in Healthy Subjects
XZP-3287 combined with clarithromycin, XZP-3287 combined with rifampicin - Healthy
Phase 1UnknownXuanzhu Biopharmaceutical Co., Ltd.602021-07-012021-07-27
A Study of Vonoprazan in Adults With Helicobacter Pylori
Clarithromycin, Amoxicillin, Bismuth potassium citrate - Helicobacter Pylori
Phase 1CompletedTakeda442021-04-062023-08-31
Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers
JP-1366 20mg 1capsule, Amoxicillin 500Mg Cap, Clarithromycin 500Mg Tab - Helicobacter Pylori Associated Gastrointestinal Disease
Phase 1CompletedOnconic Therapeutics Inc.292020-11-182022-01-18
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
Zanubrutinib, Fluconazole, Diltiazem - B-cell Malignancies
Phase 1CompletedBeiGene262020-11-152024-10-26

Showing 20 of 68. Sign in to see all of them.

Conditions studied

HIV Infections (3)  ·  AIDS-Related Opportunistic Infections (2)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Parkinson Disease (2)  ·  AIDS-Related Complex (1)  ·  Alzheimer Disease (1)  ·  Anemia, Hemolytic (1)  ·  Anovulation (1)  ·  Bacterial Infections (1)  ·  Depressive Disorder, Major (1)  ·  Lymphoma (1)  ·  Multiple Myeloma (1)  ·  Mycobacterium avium-intracellulare Infection (1)  ·  Mycoses (1)  ·  Neoplasm Metastasis (1)

Sponsors

Eli Lilly and Company (4)  ·  Boehringer Ingelheim (3)  ·  Janssen Research & Development, LLC (3)  ·  Mylan Pharmaceuticals Inc (3)  ·  Takeda (3)  ·  HK inno.N Corporation (2)  ·  Sandoz (2)  ·  Seoul National University Hospital (2)  ·  Teva Pharmaceuticals USA (2)  ·  Abbott (1)  ·  Antios Therapeutics, Inc (1)  ·  BeiGene (1)  ·  Bristol-Myers Squibb (1)  ·  CTI BioPharma (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)

Countries

United States (21)  ·  South Korea (10)  ·  China (9)  ·  Canada (5)  ·  Belgium (4)  ·  Australia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Japan (1)  ·  Pakistan (1)  ·  Portugal (1)  ·  Russia (1)

Top investigators

Eric Sicard, M.D. (3)  ·  James D Carlson, Pharm. D. (2)  ·  Joo-Youn Cho (2)  ·  So Ran Hong, M.D. (2)  ·  Alla Andreeva, PhD (1)  ·  Elena Smolyarchuk, PhD (1)  ·  Frank Farmer, MD, PhD (1)  ·  Henrik E Poulsen, dr. med. (1)  ·  Husson R (1)

Results publications

PMID 15470330, PMID 21480191, PMID 24919854, PMID 26872892, PMID 27928738, PMID 28783865, PMID 28800141, PMID 29846770, PMID 30352784, PMID 31030414, PMID 32274381, PMID 33062627, PMID 33128208, PMID 36480811, PMID 37393120, PMID 37440779, PMID 38826786, PMID 40948663

NIH funding

2014 (3), 2009 (1), 2018 (1), R01NS099535 (1)